Mayne Pharma Appoints former AstraZeneca leader as new CEO
- Mayne Pharma (MYX) appoints Shawn Patrick O’Brien as its new CEO and Managing Director
- Following the retirement of Scott Richards, announced last month, Mr O’Brien will take the reigns on October 1
- MYX says with over 35 years of experience in the global pharmaceutical industry, including 17 years at AstraZeneca, the new CEO is an “ideal choice” to lead the company
- The company says Mr O’Brien has “a proven ability” to turn around organisations, lead large and diverse teams, and deliver growth within both public and private companies
- MYX shares are up 4.9 per cent trading at 27 cents at 1:36 pm AEST
